When physicians initiate insulin therapy in patients with T2DM, metformin should be continued while other oral agents may be continued or discontinued on an individual basis, especially insulin regimens to avoid unnecessarily complex or costly OHA regimens
14.5 MOUNJARO Use in Combination with Metformin or Basal Insulin, or Both in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy
Simple Sugars and Refined Carbohydrates : These can cause blood sugar spikes
Injections to Enhance Your IV Therapy Boost your metabolism and energy naturally with Vitamin B12 and amino acids
The variants included in this report do not represent the majority of the BRCA1/BRCA2 variants in people of most ethnicities
If youre doing keto or trying to limit your sugar for other health reasons, just one high-sugar energy drink can kill your goals
.png)
